uric acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We retrospectively collected data of LA-HNSCC patients treated at our Institution from 2008 to 2019." | 1.91 | Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience. ( Alfieri, S; Barretta, F; Bergamini, C; Calareso, G; Cavalieri, S; Colombo, E; Cosmai, L; De Feo, G; Di Pede, P; Franceschini, M; Gandelli, M; Guglielmo, M; Iacovelli, NA; Licitra, L; Nuzzolese, I; Ottini, A; Platini, F; Resteghini, C; Ripamonti, CI; Toffolatti, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalieri, S | 1 |
| Platini, F | 1 |
| Barretta, F | 1 |
| Nuzzolese, I | 1 |
| Ottini, A | 1 |
| Bergamini, C | 1 |
| Resteghini, C | 1 |
| Colombo, E | 1 |
| Iacovelli, NA | 1 |
| Franceschini, M | 1 |
| Calareso, G | 1 |
| Di Pede, P | 1 |
| De Feo, G | 1 |
| Gandelli, M | 1 |
| Toffolatti, L | 1 |
| Guglielmo, M | 1 |
| Ripamonti, CI | 1 |
| Cosmai, L | 1 |
| Licitra, L | 1 |
| Alfieri, S | 1 |
1 other study available for uric acid and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Topics: Acute Kidney Injury; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; | 2023 |